Long-term clinical outcomes in patients with autoimmune hepatitis according to treatment response in Asian country.

Jonggi ChoiGwang Hyeon ChoiDanbi LeeJu Hyun ShimYoung-Suk LimHan Chu LeeYoung-Hwa ChungYung-Sang LeeKang Mo Kim

Published in: Liver international : official journal of the International Association for the Study of the Liver (2019)

Patients with CBR within 1 year after treatment initiation had the lowest risk of liver-related adverse outcomes. Patients with late CBR and those with only BR had a comparable risk of long-term outcomes.

Keyphrases

multiple sclerosis
drug induced